Therefore, the blockade of the APE1 redox function, e.g., with compound APX3330, has been extensively characterized and represents a promising strategy to alter cell survival and growth of different type of solid tumors and leukemias (acute lymphoblastic leukemia in particular) [31]. The gene discussed is APEX1; the disease is acute lymphoblastic leukemia.